130 related articles for article (PubMed ID: 38314662)
1. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Nishiwaki S; Sugiura I; Fujisawa S; Hatta Y; Atsuta Y; Doki N; Kurahashi S; Ueda Y; Dobashi N; Maeda T; Matsumura I; Tanaka M; Kako S; Ichinohe T; Fukuda T; Ohtake S; Ishikawa Y; Miyazaki Y; Kiyoi H;
Am J Hematol; 2024 May; 99(5):806-815. PubMed ID: 38314662
[TBL] [Abstract][Full Text] [Related]
2. The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis.
Ghobadi A; Slade M; Kantarjian H; Alvarenga J; Aldoss I; Mohammed KA; Jabbour E; Faramand R; Shah B; Locke F; Fingrut W; Park JH; Short NJ; Gao F; Uy GL; Westervelt P; DiPersio JF; Champlin RE; Al Malki MM; Ravandi F; Kebriaei P
Blood; 2022 Nov; 140(20):2101-2112. PubMed ID: 35877996
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.
Nishiwaki S; Inamoto Y; Sakamaki H; Kurokawa M; Iida H; Ogawa H; Fukuda T; Ozawa Y; Kobayashi N; Kasai M; Mori T; Iwato K; Yoshida T; Onizuka M; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Miyamura K
Blood; 2010 Nov; 116(20):4368-75. PubMed ID: 20664060
[TBL] [Abstract][Full Text] [Related]
4. Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.
Jia X; Liao N; Yu S; Li H; Liu H; Zhang H; Xu J; Yao Y; He H; Yu G; Liu Q; Zhang Y; Shi P
Cancer Med; 2024 Feb; 13(4):e7074. PubMed ID: 38457215
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission.
Kaito S; Kurosawa S; Najima Y; Sakaida E; Shingai N; Fukuda T; Tachibana T; Uchida N; Ozawa Y; Sawa M; Nakazawa H; Ota S; Kato J; Nakamae H; Katayama Y; Eto T; Tanaka J; Kanda Y; Atsuta Y; Arai Y; Kako S;
Transplant Cell Ther; 2022 Jun; 28(6):326.e1-326.e10. PubMed ID: 35306218
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia.
Bakr M; Rasheed W; Mohamed SY; Al-Mohareb F; Chaudhri N; Al-Sharif F; Al-Zahrani H; Al-Dawsari G; Saleh AJ; Nassar A; Ahmed S; Elghazaly A; Ahmed SO; Ibrahim K; Chebbo W; El Gohary GM; Al Mahayni MH; Hussain F; Nurgat Z; Elhassan TA; Walter CU; Aljurf M
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1897-904. PubMed ID: 22824185
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis.
Wei H; Kuang P; Liu T
Ann Hematol; 2020 Nov; 99(11):2619-2628. PubMed ID: 32960314
[TBL] [Abstract][Full Text] [Related]
8. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Nishiwaki S; Miyamura K; Ohashi K; Kurokawa M; Taniguchi S; Fukuda T; Ikegame K; Takahashi S; Mori T; Imai K; Iida H; Hidaka M; Sakamaki H; Morishima Y; Kato K; Suzuki R; Tanaka J;
Ann Oncol; 2013 Jun; 24(6):1594-602. PubMed ID: 23372050
[TBL] [Abstract][Full Text] [Related]
9. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
Ferra Coll C; Morgades de la Fe M; Prieto García L; Vaz CP; Heras Fernando MI; Bailen Almorox R; Garcia-Cadenas I; Calabuig Muñoz M; Ripa TZ; Zanabili Al-Sibai J; Novoa S; Aguado B; Torrent Catarineu A; López-Godino O; Martino Bofarull R; Kwon M; Campos Júnior A; Caballero Barrigón D; Ribera Santasusana JM
Eur J Haematol; 2023 Jun; 110(6):659-668. PubMed ID: 36813736
[TBL] [Abstract][Full Text] [Related]
11. Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review.
Warraich Z; Tenneti P; Thai T; Hubben A; Amin H; McBride A; Warraich S; Hannan A; Warraich F; Majhail N; Kalaycio M; Anwer F
Biol Blood Marrow Transplant; 2020 Mar; 26(3):e55-e64. PubMed ID: 31557532
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xie M; Shi T; Jiang Q; Jia Y; Zhou D; Tong H; Jin J; Zhu HH
Cancer; 2023 May; 129(10):1523-1536. PubMed ID: 36882308
[TBL] [Abstract][Full Text] [Related]
13. Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lyu M; Jiang E; He Y; Yang D; Ma Q; Pang A; Zhai W; Wei J; Huang Y; Zhang G; Zhang R; Feng S; Han M
Hematology; 2021 Dec; 26(1):65-74. PubMed ID: 33402056
[No Abstract] [Full Text] [Related]
14. [Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic stem cell transplantation in CR1 as the front-line therapy for adult Ph(+) acute lymphoblastic leukemia].
Huang J; Zou DH; Fu MW; Li ZJ; Xu Y; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):673-8. PubMed ID: 22339825
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Philadelphia Chromosome Karyotype and Allogeneic Hematopoietic Stem Cell Transplantation on Patients with Acute Lymphoblastic Leukemia].
Wang Y; Xu XM; Zhang M; Wang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1397-1406. PubMed ID: 36208241
[TBL] [Abstract][Full Text] [Related]
16. Comparison of allogeneic hematopoietic stem cell transplantation and TKI combined with chemotherapy for adult philadelphia chromosome positive acute lymphoblastic leukemia: a systematic review and meta-analysis.
Zeng Q; Xiang B; Liu Z
Cancer Med; 2021 Dec; 10(24):8741-8753. PubMed ID: 34761879
[TBL] [Abstract][Full Text] [Related]
17. A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation.
Cao LQ; Zhou Y; Liu YR; Xu LP; Zhang XH; Wang Y; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Liu KY; Fan QZ; Chang YJ; Huang XJ
Chin Med J (Engl); 2021 Mar; 134(10):1199-1208. PubMed ID: 33734137
[TBL] [Abstract][Full Text] [Related]
18. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
[TBL] [Abstract][Full Text] [Related]
19. Effects of different types of allogeneic hematopoietic stem cell transplantation donors on Philadelphia chromosome-positive acute lymphoblastic leukemia during the tyrosine kinase inhibitor era: A systematic review and meta-analysis.
Ponvilawan B; Owattanapanich W; Charoenngam N; Kungwankiattichai S
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):197-208. PubMed ID: 34743893
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Cornelissen JJ; van der Holt B; Verhoef GE; van't Veer MB; van Oers MH; Schouten HC; Ossenkoppele G; Sonneveld P; Maertens J; van Marwijk Kooy M; Schaafsma MR; Wijermans PW; Biesma DH; Wittebol S; Voogt PJ; Baars JW; Zachée P; Verdonck LF; Löwenberg B; Dekker AW;
Blood; 2009 Feb; 113(6):1375-82. PubMed ID: 18988865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
